{
    "2019-03-19": [
        [
            {
                "time": "2019-03-19",
                "original_text": "Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer",
                "features": {
                    "keywords": [
                        "discontinuation",
                        "Phase III",
                        "JAVELIN",
                        "Ovarian Cancer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Dow Snaps Win Streak on U.S.-China Trade Concerns",
                "features": {
                    "keywords": [
                        "Dow",
                        "U.S.-China",
                        "Trade Concerns"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Pfizer (PFE) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "After Hours Most Active for Mar 19, 2019 : TFCFA, TFCF, LLY, BRX, TWTR, BAC, PFE, EBAY, S, MSFT, CMCSA, INTC",
                "features": {
                    "keywords": [
                        "After Hours",
                        "Most Active",
                        "Mar 19"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Market Close Report: NASDAQ Composite index closes at 7,723.95 up 9.47 points",
                "features": {
                    "keywords": [
                        "NASDAQ",
                        "Composite",
                        "up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Analysts Reduce Pfizerâ€™s Target Price in March",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Reduce",
                        "Target Price",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Why You Should Buy ABBV Stock for Income and Value",
                "features": {
                    "keywords": [
                        "Buy",
                        "ABBV",
                        "Income",
                        "Value"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Anti-Infective",
                        "FDA",
                        "Pediatric"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Aerie (AERI) Starts Phase II Study on Eye Candidate AR-1105",
                "features": {
                    "keywords": [
                        "Aerie",
                        "Phase II",
                        "Study",
                        "AR-1105"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "3 Stocks to Build Your Portfolio Around",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Webcast",
                        "Conference Call"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Health Care Sector Update for 03/19/2019: TYHT, ALT, AQB, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "TYHT",
                        "ALT",
                        "AQB",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Bristol-Myers & Pfizer Release Phase IV Data on Eliquis",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Pfizer",
                        "Phase IV",
                        "Eliquis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}